Literature DB >> 28241250

Increasing the Use of Lithium and Clozapine in US Suicide Prevention.

Tarun Bastiampillai1, Steven S Sharfstein2, Stephen Allison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28241250     DOI： 10.1001/jamapsychiatry.2016.3866

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  4 in total

Review 1.  Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?

Authors:  Gabriele Sani; Giulio Perugi; Leonardo Tondo
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

Review 2.  Suicide Risk Assessment and Prevention: Challenges and Opportunities.

Authors:  Eileen P Ryan; Maria A Oquendo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

3.  Forty years without mental hospitals in Italy.

Authors:  Corrado Barbui; Davide Papola; Benedetto Saraceno
Journal:  Int J Ment Health Syst       Date:  2018-07-31

Review 4.  Candidate Biomarkers of Suicide Crisis Syndrome: What to Test Next? A Concept Paper.

Authors:  Raffaella Calati; Charles B Nemeroff; Jorge Lopez-Castroman; Lisa J Cohen; Igor Galynker
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-21       Impact factor: 5.176
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.